2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Combat Disorders: new trials by email Literature Review of Combat Disorders trials Research Report on Combat Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tramadol Extended-Release (ER) for Posttraumatic Stress Disorder (PTSD) Tramadol, Placebo - Post-Traumatic Stress Disorder | Phase 4 | Completed | INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium | 40 | 2011-09-01 | 2022-08-31 |
| Quetiapine Augmentation for Treatment-resistant PTSD Open Label (OL) Paroxetine, Placebo, Quetiapine - Combat Disorders, Stress Disorders, Post-Traumatic | Phase 4 | Completed | VA Office of Research and Development | 124 | 2006-01-01 | 2019-10-16 |
Stress Disorders, Post-Traumatic (2)
Mental Disorders (2) · Stress Disorders, Traumatic (2) · Trauma and Stressor Related Disorders (2)
Paroxetine (1) · Quetiapine Fumarate (1) · Sugars (1) · Tramadol (1)
INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium (1) · VA Office of Research and Development (1)
United States (2)
Mark B Hamner, MD BS (1) · Thomas Geracioti, MD (1)